SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phil Cressman who wrote (721)5/5/1998 5:32:00 PM
From: Tom Caruthers  Read Replies (1) of 2135
 
Phil,

I am sorry to hear about your wife.

There is no question about it, everyone needs to make their own decisions about when to buy and sell. I was not saying that people should not buy or should not sell. What I was saying is that there is more at stake here than just money. Do what you want with the stock.

Don't forget that this drug, whenever it may actually go to clinical trials, will be on a fast track for FDA approval. As a lead priority for the NCI, this is not one of those drugs that will get lost in a sea of paperwork. Also, the clinical trials may not take as long as everyone expects....if these peptides actually work, there will be a clear indications early on...compassionate use....

Anyway, I think the key to this company is to actually get enough protein to try this out in humans. Once that happens, I think that we will see things pick up quickly. That is the big question for me.

Take care,
Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News